dr. crafton on optimizing treatment selection in recurrent ovarian cancer
Published 4 years ago • 206 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:58
dr. crafton on the impact of parp inhibitors in recurrent ovarian cancer
-
1:07
dr. crafton on secondary surgical cytoreduction in ovarian cancer
-
0:49
dr. crafton on considerations for secondary cytoreduction in ovarian cancer
-
1:30
dr. mirza on the evolving treatment landscape in recurrent ovarian cancer
-
6:03
novel treatment strategies in recurrent ovarian cancer
-
3:08
ovarian cancer: optimizing treatment with niraparib
-
6:20
parp inhibitors in recurrent ovarian cancer
-
7:26
emerging therapies in recurrent ovarian cancer
-
9:08
factors in choice of treatment for recurrent ovarian cancer
-
1:18
dr. backes on treatment selection with parp inhibitors in ovarian cancer
-
7:34
parp inhibition’s role in recurrent ovarian cancer
-
4:07
expert approaches for treating recurrent ovarian cancer
-
2:35
dr. monk on choosing between parp inhibitors in ovarian cancer
-
2:53
neoadjuvant therapy versus surgery for ovarian cancer
-
1:24
dr. ledermann on response to rucaparib in recurrent ovarian cancer
-
0:49
dr. matulonis on cps as a potential biomarker in advanced recurrent ovarian cancer
-
1:30
dr. fowler on considerations for cytoreductive surgery in ovarian cancer
-
3:22
novel combination strategies in recurrent ovarian cancer
-
2:18
dr. mirza on efficacy of niraparib/bevacizumab combo in recurrent ovarian cancer